COMPLETE SKIN CLEARANCE IS NOT ATTAINED BY MOST PATIENTS RECEIVING BIOLOGICS FOR MODERATE TO SEVERE PLAQUE PSORIASIS: INTERIM RESULTS OF AN INTERNATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY

被引：0
|
作者：
Augustin, M. [1 ]
Lacour, J. [2 ]
Reich, K. [3 ]
Horne, L. [4 ]
Williams, A. [4 ]
Horton, J. [5 ]
Slynn, G. [6 ]
Hammond, E. R. [4 ]
机构：
[1] Univ Med Ctr Hamburg, Hamburg, Germany
[2] Hop Archet, Nice, France
[3] Dermatologikum Hamburg, Hamburg, Germany
[4] AstraZeneca, Gaithersburg, MD USA
[5] Clin Solut Grp, Raleigh, NC USA
[6] AstraZeneca, Alderley Pk, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1321
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY7
引用
下载
收藏
页码：A575 / A575
页数：1
相关论文
共 50 条
  • [31] Real-World Experience of Secukinumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis in Greece: 3-Year Interim Results of the SERENA Study
    Ioannides, Dimitrios
    Rigopoulos, Dimitrios
    Papakonstantis, Markos
    Chasapi, Vasiliki
    Deligiannis, Panagiotis
    Rigatos, Panagiotis
    Lefaki, Ioanna
    Papadavid, Evangelia
    Pokas, Eteoklis
    Tsilifis, Spyridon
    Roussaki-Schulze, Angeliki-Viktoria
    Barkis, Ioannis
    Lazaridou, Elisabeth
    Fotiadou, Christina
    Zisimou, Chrysa
    Kallidis, Panagiotis
    Chatzakis, Vasileios
    Oikonomou, Chrysa
    Madia, Xenia
    DERMATOLOGIC THERAPY, 2024, 2024
  • [32] Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting
    Lynde, Charles
    Riedl, Elisabeth
    Maul, Julia-Tatjana
    Torres, Tiago
    Pinter, Andreas
    Fabbrocini, Gabrielle
    Daniele, Flavia
    Brnabic, Alan
    Reed, Catherine
    Wilhelm, Stefan
    Holzkamper, Thorsten
    Schuster, Christopher
    Puig, Luis
    ADVANCES IN THERAPY, 2023, 40 (03) : 869 - 886
  • [33] Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting
    Charles Lynde
    Elisabeth Riedl
    Julia-Tatjana Maul
    Tiago Torres
    Andreas Pinter
    Gabrielle Fabbrocini
    Flavia Daniele
    Alan Brnabic
    Catherine Reed
    Stefan Wilhelm
    Thorsten Holzkämper
    Christopher Schuster
    Luis Puig
    Advances in Therapy, 2023, 40 : 869 - 886
  • [34] Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis - nationwide results from the DERMBIO registry
    Egeberg, A.
    Iversen, L.
    Gniadecki, R.
    Hvid, L.
    Dam, T. N.
    Bryld, L. E.
    Skov, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (07) : 1183 - 1187
  • [35] Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
    Li, Ying
    Lv, Chengzhi
    Dang, Lin
    Lin, Bingjiang
    Tao, Juan
    Zhang, Chunlei
    Zhou, Xiaoyong
    Ma, Han
    Lu, Yi
    Chen, Rong
    Li, Jinnan
    Dou, Guanshen
    Liang, Yunsheng
    Liang, Yanhua
    Shi, Yuling
    DERMATOLOGY AND THERAPY, 2024, 14 (04) : 907 - 918
  • [36] Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
    Ying Li
    Chengzhi Lv
    Lin Dang
    Bingjiang Lin
    Juan Tao
    Chunlei Zhang
    Xiaoyong Zhou
    Han Ma
    Yi Lu
    Rong Chen
    Jinnan Li
    Guanshen Dou
    Yunsheng Liang
    Yanhua Liang
    Yuling Shi
    Dermatology and Therapy, 2024, 14 : 907 - 918
  • [37] Ixekizumab sustained complete clearance, itch resolution, and improved quality of life for moderate-to-severe psoriasis patients who achieved rapid, high skin clearance
    Rosmarin, David
    Gooderham, Melinda
    Ferris, Laura
    See, Kyoungah
    Wolf, Eric
    Burge, Russel
    McKean-Matthews, Missy
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB68 - AB68
  • [38] Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS)
    Charles W. Lynde
    Maryam S. Alam
    Kamal Ohson
    Angélique Gagné-Henley
    Miriam Avadisian
    Ronald B. Vender
    Dermatology and Therapy, 2022, 12 : 921 - 931
  • [39] Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS)
    Lynde, Charles W.
    Alam, Maryam S.
    Ohson, Kamal
    Gagne-Henley, Angelique
    Avadisian, Miriam
    Vender, Ronald B.
    DERMATOLOGY AND THERAPY, 2022, 12 (04) : 921 - 931
  • [40] Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study
    Blauvelt, Andrew
    Armstrong, April W.
    Langley, Richard G.
    Gebauer, Kurt
    Thaci, Diamant
    Bagel, Jerry
    Guenther, Lyn C.
    Paul, Carle
    Randazzo, Bruce
    Flavin, Susan
    Hsu, Ming-Chun
    You, Yin
    Reich, Kristian
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2317 - 2324
12345